These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20338785)

  • 1. Development, standardization and assessment of PCR systems for purity testing of avian viral vaccines.
    Ottiger HP
    Biologicals; 2010 May; 38(3):381-8. PubMed ID: 20338785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-validation study for testing of avian viral vaccines for extraneous agents by PCR.
    Bruckner L; Ottiger HP
    Pharmeuropa Bio; 2007 Dec; 2007(1):15-8. PubMed ID: 18413134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the sensitivity of PCR methods for the detection of extraneous agents and comparison with in vivo testing.
    Motitschke A; Ottiger HP; Jungbäck C
    Biologicals; 2010 May; 38(3):389-92. PubMed ID: 20338784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of PCR for extranous agent testing in avian vaccines.
    Ottiger HP
    Dev Biol (Basel); 2002; 111():23-6. PubMed ID: 12678221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extraneous agents testing for substrates of avian origin and viral vaccines for poultry: current provisions and proposals for future approaches.
    Jungbäck C; Motitschke A
    Biologicals; 2010 May; 38(3):362-5. PubMed ID: 20335053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring veterinary vaccines for contaminating viruses.
    Ottiger HP
    Dev Biol (Basel); 2006; 126():309-19; discussion 327. PubMed ID: 17058507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory host systems for extraneous agent testing in avian live virus vaccines: problems encountered.
    Philipp HC; Kolla I
    Biologicals; 2010 May; 38(3):350-1. PubMed ID: 20335050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Sybr Green I, ELISA and conventional agarose gel-based PCR in the detection of infectious bursal disease virus.
    Hairul Aini H; Omar AR; Hair-Bejo M; Aini I
    Microbiol Res; 2008; 163(5):556-63. PubMed ID: 16971101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a multiplex PCR for detection of avian adenovirus, avian reovirus, infectious bursal disease virus, and chicken anemia virus.
    Caterina KM; Frasca S; Girshick T; Khan MI
    Mol Cell Probes; 2004 Oct; 18(5):293-8. PubMed ID: 15294316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyses of the results of different test systems in the 2005 global proficiency testing schemes for infectious bursal disease virus and Newcastle disease virus antibody detection in chicken serum.
    de Wit JJ; van de Sande HW; Counotte GH; Wellenberg GJ
    Avian Pathol; 2007 Apr; 36(2):177-83. PubMed ID: 17479380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral safety and extraneous agents testing for veterinary vaccines: rationale for requirements, the European approach.
    Bruckner L
    Biologicals; 2010 May; 38(3):338-9. PubMed ID: 20335051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of an infectious bursal disease virus intermediate vaccine in ovo.
    Coletti M; Del Rossi E; Franciosini MP; Passamonti F; Tacconi G; Marini C
    Avian Dis; 2001; 45(4):1036-43. PubMed ID: 11785875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid comparison of infectious bursal disease viruses placed in the same or different molecular groups by RT/PCR-RFLP.
    Jackwood DJ; Sommer SE; Knoblich HV
    Avian Dis; 2001; 45(2):330-9. PubMed ID: 11417812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody detection in matched chicken sera and egg-yolk samples by commercial enzyme-linked immunosorbent assay kits for Newcastle disease virus, infectious bronchitis virus, infectious bursal disease virus, and avian reovirus.
    Keck LD; Skeeles JK; McNew RW
    Avian Dis; 1993; 37(3):825-8. PubMed ID: 8257378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poultry vaccines: an analysis of the animal trials required for vaccine testing and the way to reduce or refine these tests.
    Jungbäck C; Küchler B; Schirk EM
    Dev Biol Stand; 1999; 101():79-83. PubMed ID: 10566779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenicity, attenuation, and immunogenicity of infectious bursal disease virus.
    Hassan MK; Al-Natour MQ; Ward LA; Saif YM
    Avian Dis; 1996; 40(3):567-71. PubMed ID: 8883785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic heterogeneity in the VP2 gene of infectious bursal disease viruses detected in commercially reared chickens.
    Jackwood DJ; Sommer SE
    Avian Dis; 1998; 42(2):321-39. PubMed ID: 9645324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the host system on the pathogenicity, immunogenicity, and antigenicity of infectious bursal disease virus.
    Hassan MK; Saif YM
    Avian Dis; 1996; 40(3):553-61. PubMed ID: 8883783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on naturally occurring infectious bursal disease viruses suggest that a single amino acid substitution at position 253 in VP2 increases pathogenicity.
    Jackwood DJ; Sreedevi B; LeFever LJ; Sommer-Wagner SE
    Virology; 2008 Jul; 377(1):110-6. PubMed ID: 18502466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avian adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chickens.
    Francois A; Chevalier C; Delmas B; Eterradossi N; Toquin D; Rivallan G; Langlois P
    Vaccine; 2004 Jun; 22(17-18):2351-60. PubMed ID: 15149796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.